CONMED Corp (CNMD) stock
CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3028% below fair value
$46.56+0.18 (+0.39%)
Close on Nov 20, 2026Market cap $1.39BP/E 19.2Yield 1.29%
Conmed free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Conmed's free cash flow for the twelve months ending Sep 30, 2026 was $132.69M, down 10.9% year over year. For fiscal 2025 it was $150.88M, down 2.0% from the year before. Over ten years it grew 15.4% a year on average. The highest annual figure on record is $153.88M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $150.88M | -2.0% |
| FY2024 | Dec 31, 2024 | $153.88M | +44.7% |
| FY2023 | Dec 31, 2023 | $106.32M | +818.1% |
| FY2022 | Dec 31, 2022 | $11.58M | -88.1% |
| FY2021 | Dec 31, 2021 | $96.90M | +88.1% |
| FY2020 | Dec 31, 2020 | $51.52M | -31.4% |
| FY2019 | Dec 31, 2019 | $75.07M | +29.0% |
| FY2018 | Dec 31, 2018 | $58.19M | +10.4% |
| FY2017 | Dec 31, 2017 | $52.72M | +109.8% |
| FY2016 | Dec 31, 2016 | $25.13M | -30.0% |
| FY2015 | Dec 31, 2015 | $35.91M | -27.8% |
| FY2014 | Dec 31, 2014 | $49.77M | -20.4% |
| FY2013 | Dec 31, 2013 | $62.50M | -15.2% |
| FY2012 | Dec 31, 2012 | $73.67M | -13.8% |
| FY2011 | Dec 31, 2011 | $85.44M | +263.4% |
| FY2010 | Dec 31, 2010 | $23.51M | +556.0% |
| FY2009 | Dec 31, 2009 | $3.58M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $46.73M | -3.7% |
| Q2 FY2026 | Jun 30, 2026 | $34.16M | +46.0% |
| Q1 FY2026 | Mar 31, 2026 | $10.58M | -72.0% |
| Q4 FY2025 | Dec 31, 2025 | $41.22M | +4.9% |
| Q3 FY2025 | Sep 30, 2025 | $48.50M | +1.5% |
| Q2 FY2025 | Jun 30, 2025 | $23.41M | -41.1% |
| Q1 FY2025 | Mar 31, 2025 | $37.76M | +39.4% |
| Q4 FY2024 | Dec 31, 2024 | $39.30M | -23.8% |
| Q3 FY2024 | Sep 30, 2024 | $47.78M | +17.3% |
| Q2 FY2024 | Jun 30, 2024 | $39.72M | +79.4% |
| Q1 FY2024 | Mar 31, 2024 | $27.09M | – |
| Q4 FY2023 | Dec 31, 2023 | $51.54M | – |
| Q3 FY2023 | Sep 30, 2023 | $40.73M | +112.4% |
| Q2 FY2023 | Jun 30, 2023 | $22.14M | +69.9% |
| Q1 FY2023 | Mar 31, 2023 | -$8.10M | – |
| Q4 FY2022 | Dec 31, 2022 | -$17.27M | -156.5% |
| Q3 FY2022 | Sep 30, 2022 | $19.18M | +21.5% |
| Q2 FY2022 | Jun 30, 2022 | $13.03M | -58.3% |
| Q1 FY2022 | Mar 31, 2022 | -$3.36M | -117.5% |
| Q4 FY2021 | Dec 31, 2021 | $30.60M | +80.0% |
| Q3 FY2021 | Sep 30, 2021 | $15.79M | -50.4% |
| Q2 FY2021 | Jun 30, 2021 | $31.29M | +1650.7% |
| Q1 FY2021 | Mar 31, 2021 | $19.24M | +2046.8% |
| Q4 FY2020 | Dec 31, 2020 | $17.00M | -51.0% |
| Q3 FY2020 | Sep 30, 2020 | $31.84M | +0.3% |
| Q2 FY2020 | Jun 30, 2020 | $1.79M | -89.2% |
| Q1 FY2020 | Mar 31, 2020 | $896.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $34.69M | +73.9% |
| Q3 FY2019 | Sep 30, 2019 | $31.73M | – |
| Q2 FY2019 | Jun 30, 2019 | $16.59M | -3.1% |
| Q1 FY2019 | Mar 31, 2019 | -$7.94M | -137.4% |
| Q4 FY2018 | Dec 31, 2018 | $19.95M | +16.0% |
| Q3 FY2018 | Sep 30, 2018 | -$109.00K | -101.1% |
| Q2 FY2018 | Jun 30, 2018 | $17.12M | +30.8% |
| Q1 FY2018 | Mar 31, 2018 | $21.24M | +67.1% |
| Q4 FY2017 | Dec 31, 2017 | $17.20M | +83.5% |
| Q3 FY2017 | Sep 30, 2017 | $9.72M | – |
| Q2 FY2017 | Jun 30, 2017 | $13.09M | – |
| Q1 FY2017 | Mar 31, 2017 | $12.71M | – |
| Q4 FY2016 | Dec 31, 2016 | $9.38M | – |
See a number that looks wrong?